Latest action: Referred to the House Committee on Energy and Commerce.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Directs NIH and HHS to study hormone changes and testing during perimenopause in women.
The problem
Women going through perimenopause often lack adequate hormone testing and medical understanding. Better research could improve diagnosis and treatment of symptoms during this life stage.
The proposal
The bill orders NIH to evaluate hormone variability during perimenopause and HHS to review hormone testing approaches for women during this transition period.
The impact
Women experiencing perimenopause, healthcare providers, and medical researchers would benefit from improved understanding of hormone changes and better testing guidelines.
Improved research on perimenopause could help doctors better diagnose and treat symptoms like hot flashes and mood changes. Women would get more personalized and effective care during this important life stage.
This bill focuses on evaluation and review rather than new programs. It primarily directs existing agencies to study the issue, which requires minimal new federal spending.
Better understanding of hormone variability could lead to medical breakthroughs and improved treatment options. This research benefits the broader medical community and future patients.
Perimenopause affects millions of women but has received less research attention than other health conditions. This bill helps focus resources on an understudied area.
The bill doesn't specify what evaluations should include, timelines, or expected outcomes. Agencies may struggle with vague instructions on how to conduct the review.
While research-focused, conducting comprehensive hormone evaluations and testing reviews could require significant NIH and HHS resources. The actual cost remains unknown.
Directing study doesn't guarantee practical improvements or that findings will lead to policy changes. Implementation of recommendations may face barriers.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
No donor data found for current cycle
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.